.jpg)
Zacks Investment Research upgraded shares of Yamana Gold (NYSE:AUY) (TSE:YRI) from a hold rating to a buy rating in a research note released on Tuesday, Zacks.com reports. Zacks Investment Research currently has $4.75 price target on the basic materials company’s stock.
According to Zacks, “Yamana Gold is a Canadian gold producer with significant gold production, gold and copper-gold development stage properties, exploration properties and land positions in all major mineral areas in Brazil. “
Get Yamana Gold alerts:
AUY has been the topic of several other research reports. Berenberg Bank reaffirmed a buy rating on shares of Yamana Gold in a research report on Thursday, July 8th. National Bank of Canada raised shares of Yamana Gold from a sector perform rating to an outperform rating in a research report on Wednesday, August 4th. TheStreet lowered shares of Yamana Gold from a b rating to a c+ rating in a research report on Friday, August 13th. Raymond James reaffirmed a market perform rating and issued a $6.50 price objective on shares of Yamana Gold in a research report on Tuesday, August 3rd. Finally, National Bank Financial reduced their target price on shares of Yamana Gold from C$7.75 to C$7.25 and set an outperform rating for the company in a research note on Friday, September 10th. Two analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of Buy and a consensus target price of $7.65.
Top Canadian Stocks To Watch For 2023: Rhino Resource Partners LP(RNO)
Rhino Resource Partners LP produces, processes, and sells coal of various steam and metallurgical grades in the United States. The company holds interests in various surface and underground coal mines located in Central Appalachia, Northern Appalachia, the Illinois Basin, and the Western Bituminous region. As of December 31, 2010, it operated 10 mines, including 5 underground and 5 surface mines located in Kentucky, Ohio, and West Virginia. The company markets its steam coal primarily to electric utility companies as fuel for their steam-powered generators; and metallurgical coal for steel and coke producers. It also engages in mining limestone from reserves located at its Sands Hill mining complex and sells it as aggregate to various construction companies and road builders. The company was founded in 2003 and is based in Lexington, Kentucky.
Advisors’ Opinion:
- [By Logan Wallace]
JPMorgan Chase & Co. set a €74.00 ($86.05) target price on Renault (EPA:RNO) in a research report report published on Thursday morning. The firm currently has a neutral rating on the stock.
- [By Logan Wallace]
Credit Suisse Group set a €73.00 ($84.88) price objective on Renault (EPA:RNO) in a research report sent to investors on Tuesday morning. The brokerage currently has a neutral rating on the stock.
- [By Ethan Ryder]
JPMorgan Chase & Co. set a €98.00 ($113.95) price target on Renault (EPA:RNO) in a research note released on Monday. The firm currently has a neutral rating on the stock.
- [By Shane Hupp]
Deutsche Bank set a €115.00 ($133.72) target price on Renault (EPA:RNO) in a report released on Friday morning. The firm currently has a buy rating on the stock.
Top Canadian Stocks To Watch For 2023: Canadian Imperial Bank of Commerce(CM)
Canadian Imperial Bank of Commerce provides various financial products, services, and advice to individual, small business, commercial, corporate, and institutional clients in Canada and internationally. The company offers retail markets services comprising personal banking, business banking, and wealth management services, as well as investment management services to retail and institutional clients. It also provides wholesale banking services, including credit, capital markets, investment banking, merchant banking, and research products and services to government, institutional, corporate, and retail clients. The company provides its services through its branch network, automated bank machines, mobile banking, and online banking site. As of June 3, 2011, it operated approximately 1,100 branches and 4,000 automated bank machines in Canada. The company was founded in 1867 and is headquartered in Toronto, Canada.
Advisors’ Opinion:
- [By Ethan Ryder]
Canadian Imperial Bank of Commerce (NYSE:CM) (TSE:CM) saw unusually large options trading activity on Monday. Traders acquired 2,517 call options on the stock. This is an increase of approximately 3,772% compared to the typical volume of 65 call options.
- [By Motley Fool Transcribing]
Canadian Imperial Bank of Commerce (NYSE:CM) Q1 2019 Earnings Conference CallFeb. 28, 2019 8:00 a.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:Operator
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Canadian Imperial Bank of Commerce (CM)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Canadian Imperial Bank of Commerce (CM)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top Canadian Stocks To Watch For 2023: UniSource Energy Corporation(UNS)
UniSource Energy Corporation engages in the electric generation and energy delivery businesses. The company?s TEP segment generates, transmits, and distributes electricity to approximately 403,000 retail electric customers, including residential, commercial, industrial, and public sector customers in southeastern Arizona. It also sells electricity to other utilities and power marketing entities. As of December 31, 2010, this segment owned or leased 2,245 MW of net generating capacity, as well as owned or participated in electric transmission and distribution system consisting of 512 circuit-miles of 500-kV lines; 1,087 circuit-miles of 345-kV lines; 379 circuit-miles of 138-kV lines; 478 circuit-miles of 46-kV lines; and 2,621 circuit-miles of lower voltage primary lines. TEP segment generates electricity from coal, gas, oil, and solar sources. The company?s UNS Gas segment distributes gas to approximately 146,500 retail customers in Mohave, Yavapai, Coconino, and Navajo c ounties in northern Arizona, as well as Santa Cruz County in southeastern Arizona. As of December 31, 2010, this segment?s transmission and distribution system consisted of approximately 30 miles of steel transmission mains, 4,211 miles of steel and plastic distribution piping, and 136,439 customer service lines. The company?s UNS Electric segment transmits and distributes electricity to approximately 91,000 retail customers consisting of residential, commercial, and industrial customers in Mohave and Santa Cruz counties. As of December 31, 2010, UNS Electric?s transmission and distribution system consisted of approximately 56 circuit-miles of 115-kV transmission lines, 271 circuit-miles of 69-kV transmission lines, and 3,599 circuit-miles of underground and overhead distribution lines. This segment also owns the 65 MW Valencia plant, as well as 39 substations having an installed capacity of 1,788,050 kilovolt amperes. The company was founded in 1902 and is based in Tucson, Arizona.
Advisors’ Opinion:
- [By Max Byerly]
Uni Select (TSE:UNS)’s stock had its “hold” rating restated by equities research analysts at TD Securities in a report issued on Friday. They currently have a C$24.00 price objective on the stock. TD Securities’ price target points to a potential upside of 8.21% from the stock’s current price.
- [By Ethan Ryder]
Uni Select (TSE:UNS) had its price target lifted by investment analysts at Macquarie from C$24.00 to C$25.00 in a report released on Wednesday. Macquarie’s price objective suggests a potential upside of 18.32% from the stock’s current price.
Top Canadian Stocks To Watch For 2023: Valeant Pharmaceuticals International Inc(VRX)
Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products in the areas of neurology, dermatology, and branded generics. It offers Wellbutrin XL to treat depressive disorders; Xenazine to treat chorea associated with Huntington?s disease; CeraVe to rebuild and repair skin barrier; and Kinerase, a cosmetic product. The company also provides Zovirax ointment to treat initial genital herpes; Xerese to treat recurrent herpes labialis; Elidel to treat atopic dermatitis; and Acanya and Atralin gels to treat acne vulgaris. In addition, it offers Cesamet to treat nausea and vomiting associated with cancer chemotherapy; Tiazac XC to treat hypertension and angina; Wellbutrin to treat depressive illness; Sublinox to treat insomnia; and Lodalis to treat hypercholesterolemia. Further, the company provides Cold-FX to strengthen immune system; Duromine/Metermine for weight loss; Difflam to treat sore throa ts; and Duro-Tuss and Rikodeine to treat dry and chesty cough, as well as various branded generics for treatments, including antibiotics, treatments for cardiovascular and neurological diseases, antifungal medications, and diabetic therapies. Additionally, it offers Bisocard to treat hypertension and angina pectoris; Flucinar, a corticosteroid ointment; and Sachol mouth ulcer gel; Bedoyecta to treat neurotic pain; M.V.I., a hospital dietary supplement for trauma and burns; Tandene to treat fever and headache; Melleril to treat anxiety and depression; and products for therapeutic classes, such as vitamin deficiency, antibacterials, and dermatology. It markets its products in the United States, Canada, Australia, New Zealand, Europe, Latin America, southeast Asia, and South Africa. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September 2010. The company was founded in 1960 and is headquartered in M ississauga, Canada.
Advisors’ Opinion:
- [By Chris Lange]
Valeant Pharmaceuticals International Inc. (NYSE: VRX) has a PDUFA action date set for October 5 for its Jemdel (halobetasol propionate 0.01%) (IDP-122) lotion. If approved, Jemdel will be the first high-potency topical steroid treatment for plaque psoriasis with dosing for as long as eight weeks.
- [By Shane Hupp]
Korea Investment CORP cut its position in shares of Valeant Pharmaceuticals (NYSE:VRX) (TSE:VRX) by 46.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 126,736 shares of the specialty pharmaceutical company’s stock after selling 109,300 shares during the quarter. Korea Investment CORP’s holdings in Valeant Pharmaceuticals were worth $2,948,000 at the end of the most recent reporting period.
- [By Ethan Ryder]
Get a free copy of the Zacks research report on Valeant Pharmaceuticals Intl (VRX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Cory Renauer]
Progenics’ first drug, Relistor for opioid-induced constipation, hasn’t been a big seller, but Valeant Pharmaceuticals (NYSE:VRX) has taken over marketing of the drug in return for a reliable royalty stream. This will allow Progenics to focus on Azedra’s potential launch and a prostate cancer imaging agent in late-stage development.
